Polymorphonuclear leukocyte accumulation in inflammatory dermal sites as measured by 51Cr-labeled cells and

Inflammation
|September 1, 1983
PubMed

Insights

Two reliable methods for quantifying polymorphonuclear leukocyte (PMN) accumulation in skin inflammation were validated using zymosan-activated plasma (ZAP) in rats. Both 51Cr-labeled PMNs and myeloperoxidase (MPO) activity accurately measured PMN influx.

Area of Science:

  • Immunology
  • Inflammation Research
  • Biomedical Science

Background:

  • Polymorphonuclear leukocytes (PMNs) are crucial in inflammatory responses.
  • Accurate quantification of PMN infiltration is essential for studying inflammation.
  • Zymosan-activated plasma (ZAP) is a common inducer of experimental skin inflammation.

Purpose of the Study:

  • To evaluate and compare two methods for quantifying PMN accumulation in inflammatory skin lesions.
  • To assess the reliability of these methods in an in vivo model.

Main Methods:

  • Experimental inflammatory skin lesions were induced in rats using intradermal injections of varying dilutions of ZAP.
  • PMN accumulation was measured using homologous 51Cr-labeled PMNs and myeloperoxidase (MPO) activity.
  • Albumin extravasation was assessed using 125I-labeled human serum albumin.

Main Results:

  • Both 51Cr-labeled PMN content and MPO activity in skin lesions were directly proportional to ZAP concentration.
  • A high correlation (r = 0.81 +/- 0.13) was observed between the 51Cr-PMN and MPO activity measurements.
  • Albumin extravasation occurred early and did not consistently parallel PMN accumulation.

Conclusions:

  • Both 51Cr-labeled PMN quantification and MPO activity are reliable methods for measuring PMN accumulation in vivo.
  • These methods provide accurate and reproducible assessments of inflammatory cell infiltration.
  • The study highlights the distinct kinetics of PMN accumulation and albumin extravasation during inflammation.